Terms: = Colorectal cancer AND XPA, XPAC, 7507, ENSG00000136936, XP1, P23025 AND Treatment
4 results:
1. Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy before Surgery for Treating Locally Advanced Rectal cancer: A Systematic Review and Meta-Analysis.
Liao CK; Kuo YT; Lin YC; Chern YJ; Hsu YJ; Yu YL; Chiang JM; Hsieh PS; Yeh CY; You JF
Curr Oncol; 2022 May; 29(5):3708-3727. PubMed ID: 35621687
[TBL] [Abstract] [Full Text] [Related]
2. Impact of single-nucleotide polymorphisms in DNA repair pathway genes on response to chemoradiotherapy in rectal cancer patients: Results from ACCORD-12/PRODIGE-2 phase III trial.
Boige V; Mollevi C; Gourgou S; Azria D; Seitz JF; Vincent M; Bigot L; Juzyna B; Miran I; Gerard JP; Laurent-Puig P
Int J Cancer; 2019 Dec; 145(11):3163-3172. PubMed ID: 31107542
[TBL] [Abstract] [Full Text] [Related]
3. Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines.
Arnould S; Hennebelle I; Canal P; Bugat R; Guichard S
Eur J Cancer; 2003 Jan; 39(1):112-9. PubMed ID: 12504667
[TBL] [Abstract] [Full Text] [Related]
4. Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivo.
Guichard S; Arnould S; Hennebelle I; Bugat R; Canal P
Anticancer Drugs; 2001 Oct; 12(9):741-51. PubMed ID: 11593056
[TBL] [Abstract] [Full Text] [Related]
